Wilson Sui, MD
Manage Your Profile
About
Dr. Wilson Sui was born and raised in Bucks County, Pennsylvania. He attended George School, a local quaker high school where he developed a passion for swimming, frisbee and football. He graduated from Cornell University with a B.A. in Biology and Economics and subsequently attended Columbia University, College of Physicians and Surgeons. He was selected as one of ten students to participate in the Columbia-Basset program where he developed an interest in quality improvement, longitudinal patient care and of course, Urology. During this time, Dr. Sui spent a productive year managing clinical trials and performing clinical outcomes research as a clinical research fellow with Dr. James McKiernan.
After graduating, Dr. Sui received his surgical/urological training at Vanderbilt University Medical Center. He then sought further sub-specialty training in endourology with Drs. Marshall Stoller and Thomas Chi at the University of California, San Francisco. His primary clinical interests include medical and surgical management of nephrolithiasis and benign prostatic hyperplasia. As a result of his fellowship training, he is one of few U.S. providers with expertise in “radiation-free” ultrasound guided percutaneous nephrolithotomy or ureteroscopy and holmium laser enucleation of the prostate (HoLEP), a minimally invasive surgical treatment for men with enlarged prostate.
Research Overview
Improving antibiotic stewardship, clinical outcomes, health services research, metabolic management of nephrolithiasis, development of novel surgical therapies
Clinical Interests: nephrolithiasis, benign prostatic hyperplasia, ureteral stricture disease; endoscopic, laparoscopic and robotic surgery; laser and acoustic fragmentation, metabolic management, minimally invasive surgical therapies for BPH
Recent Publications
-
Sui W, Yang H, Escobar MC, Maalouf F, Suarez P, Chi T, Stoller ML. Urolithiasis, 2026 Dec 1; 54 (1):Journal ArticleImproved 24-hour urine parameters associated with reduced symptomatic kidney stone recurrence
DOI:10.1007/s00240-025-01910-1 PMID: 41428069 -
Meyer N, Lee J, Liu V, Pepic L, Pearce R, Li K, Shee K, Mena J, Ahn J, Bayne D, Stoller M, Chi T, Sui W, Yang H. Urolithiasis, 2026 Feb 3; 54 (1): 46Journal ArticleEndoscopically visible Randall's plaques are an independent predictor of future stone events.
DOI:10.1007/s00240-025-01896-w PMID: 41632113 -
Camargo Maluf F, Suarez P, Velasquez MC, Momodu M, Mann U, Taguchi K, Funk JT, Bryant JE, Yang H, Sui W, Chi T. Journal of Endourology, 2026 Jan 25;Journal ArticlePostoperative Antibiotic Duration Affects Infectious Rates in High-Risk Patients Undergoing HoLEP
DOI:10.1177/08927790261415912 -
Sui W, Suarez P, Yang H, Escobar MCV, Maluf FC, Hall T, Azzawi SA, Gupta L, Chi T. BMC Urology, 2025 Dec 1; 25 (1):Journal ArticleFinancial toxicity in lower urinary tract symptoms amongst men
DOI:10.1186/s12894-025-01895-4 PMID: 40841616 -
Yang H, Higgins N, Chu S, Lee J, Meyer N, Hansen K, Saeed M, Ferreira R, Sorrentino TA, Mena J, Suarez P, Maluf FC, Sui W, Velasquez MC, Mann U, Braun H, Du J, Elmer J, Chi T, Roy S, Flake A, Gardner JM, Stoller M. 2025 Oct 28;PreprintDevelopment and validation of an ultra-low-cost, open source normothermic ex vivo organ perfusion platform.
DOI:10.1101/2025.10.27.684886 PMID: 41279679 -
Lee J, Meyer N, Parikesit D, Dick B, Manalo T, Flores H, Ferreira R, Saeed M, Wong M, Stoller M, Chi T, Sui W, Yang H. 2025 Oct 11; medRxiv,PreprintAn intraoperative methylene blue test can guide patient selection for totally tubeless percutaneous nephrolithotomy
DOI:10.1101/2025.10.02.25336921 -
Hosier GW, Beiko DT, Yang H, Sui W, Bayne D, Stoller ML, Chi TL. Eur Urol Focus, 2025 Oct 7;Journal ArticleA Multicenter Randomized Controlled Trial of Ambulatory Versus Inpatient Percutaneous Nephrolithotomy.
DOI:10.1016/j.euf.2025.09.002 PMID: 41062420